Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue ne

fiercebiotechAugust 11, 2017

Tag: Celgene , IPO , Buyout

PharmaSources Customer Service